About 1,722,060 results (5,110 milliseconds)

Diagnosis and management of epilepsies in children and young ...

https://groups.google.com/group/meta-ngo/attach/7095a77b10be207f/epilepcy.pdf?part=0.6
Focal (previously “partial”) epileptic seizures arise in specific loci in one part of the cerebral cortex that carry with them identifiable clinical features ...

US9474726B2 - Use of cannabinoids in the treatment of epilepsy ...

https://patents.google.com/patent/US9474726B2/en
Dec 17, 2015 ... Brust et al., Marijuana use and the risk of new onset seizures. Trans Am Clin Climatol Assoc. 1992;103:176-81. Carlini et al., Hypnotic and ...

US20210346096A1 - Methods and apparatus for electromagnetic ...

https://patents.google.com/patent/US20210346096A1/en
The epileptogenic tissue in the group of focal epilepsy patients who became seizure ... Dangerous driving detection method and equipment. CN115081558A ...

US20220211319A1 - Non-invasive proprioceptive stimulation for ...

https://patents.google.com/patent/US20220211319A1/en
... epilepsy, generalized tonic-clonic epilepsy and focal epilepsy in ... temporal lobe epilepsy patients at High Risk of sudden unexpected death in epilepsy.

US9956185B2 - Use of cannabinoids in the treatment of epilepsy ...

https://patents.google.com/patent/US9956185B2/en
None of the FIRES patients suffered from focal seizures with secondary generalisation or convulsive seizures. TABLE 5. Total Seizure Data. Frequency, Change, % ...

US11701330B2 - Use of cannabinoids in the treatment of epilepsy ...

https://patents.google.com/patent/US11701330B2/en
None of the FIRES patients suffered from focal seizures with secondary generalisation or convulsive seizures. TABLE 5. Total Seizure Data. Change, %, Responder ...

WO2022023839A1 - 2-(2-oxo-3-pyrolin-1-yl)acetamides as ...

https://patents.google.com/patent/WO2022023839A1/en
... focal seizures and treatments for generalized seizures. Then each seizure ... seizures, safety is a major issue to avoid serious adverse effects in humans.

US11154516B2 - Use of cannabinoids in the treatment of epilepsy ...

https://patents.google.com/patent/US11154516B2/en
... cause epilepsy in childhood. Examples of some of these are as follows: Dravet ... partial seizures (focal seizures with impairment). None of the FIRES ...

US10603288B2 - Use of cannabinoids in the treatment of epilepsy ...

https://patents.google.com/patent/US10603288B2/en
... cause epilepsy in childhood. Examples of some of these are as follows: Dravet ... partial seizures (focal seizures with impairment). None of the FIRES ...

US20220218598A1 - Methods and compositions for rapid delivery ...

https://patents.google.com/patent/US20220218598A1/en
This longer half-life provides a longer duration of action, lowering the risk of a second seizure or need for repeat dosing. [0080]. Accordingly, in some ...

WO2012154889A1 - Serum s100b and uses thereof - Google Patents

https://patents.google.com/patent/WO2012154889A1/en
... epileptic syndromes, seizure reduction was more prominent in focal epilepsy patients. (16D) Therapeutic response (set as >50%) did not correlate with ...

Bright Minds - Epilepsy

https://sites.google.com/view/bright-minds-epilepsy
Pharma co-resistance develops in about 20% of patients with primary generalized epilepsy and up to 60% of patients with focal epilepsy. Helping The Brain In ...

US10485471B2 - System and method for identifying ictal states in a ...

https://patents.google.com/patent/US10485471B2/en
Microphone: Dysphasia (impaired language production) and speech automatisms often occur during focal epileptic seizures. ... The most serious seizure ...

WO2011057199A1 - Compositions for treating cns disorders ...

https://patents.google.com/patent/WO2011057199A1/en
... dangerous and very difficult ... [0051] In certain embodiments, provided combinations are useful in the treatment of seizure disorders, including epilepsy.

GB2530001A - Use of cannabidiol in the reduction of convulsive ...

https://patents.google.com/patent/GB2530001A/en
Other seizures develop between one and four years of age such as prolonged focal dyscognitive seizures and brief absence seizures. ... cause epilepsy in childhood ...

CN113966400A - Interneuron-specific therapeutic agents for ...

https://patents.google.com/patent/CN113966400A/en
... epilepsy, including focal and pharmacologically refractory epilepsy, and DS. ... cause behind seizures representing the most dangerous symptoms of DS syndrome.

JP2023515624A - Method of treating tuberous sclerosis with ...

https://patents.google.com/patent/JP2023515624A/en
... dangerous levels. There is a risk of. 目的の薬物は、プロトタイプのCYP3A4 ... The focal seizure of claim 10, wherein the focal seizure is a focal motor ...

CN1446100B - Method for treating movement disorder - Google ...

https://patents.google.com/patent/CN1446100B/en
The a kind of of focal epilepsy is the ideomotor movement epilepsy.Present ... cause significant sensation denervation dangerous or desirable with the ...

WO2017221040A2 - Genetic diagnostics of intellectual disability ...

https://patents.google.com/patent/WO2017221040A2/en
Risk of epilepsy in the ... (2010) Genome-wide copy number variation in epilepsy: novel susceptibility loci in idiopathic generalized and focal epilepsies.

JP2008513466A - Use of 2-phenyl-1,2-ethanediol (DI) carbamate to ...

https://patents.google.com/patent/JP2008513466A/en
... seizures, particularly epileptic seizures. Thus, such methods treat and prevent epilepsy and epileptic seizures, reduce the risk of epileptic onset, and ...